Target Identification
CRISPR/Cas Design
Boosting with drugs
In vivo Delivery
Company | Cascure Therapeutics |
---|---|
Founding | 2020.06.30 |
CEO | Jongmoon Kim |
Head Office | UNIST, Ulsan, Korea |
R&D center | Magok, Seoul, Korea |
Shareholders (Jan. 2025) |
Founder and management (60.94%) / Individuals (3.92%) 3 Investments (25.53%) / 2 Researches institute (3.84%) Private Investment Funds (5.77%) |